Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan
- PMID: 15118546
- DOI: 10.1097/01.md.0000126763.68170.46
Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan
Abstract
: To determine and directly compare the clinical course of white and Asian patients with paroxysmal nocturnal hemoglobinuria (PNH), data were collected for epidemiologic analysis on 176 patients from Duke University and 209 patients from Japan. White patients were younger with significantly more classical symptoms of PNH including thrombosis, hemoglobinuria, and infection, while Asian patients were older with more marrow aplasia. The mean fraction of CD59-negative polymorphonuclear cells (PMN) at initial analysis was higher among Duke patients than Japanese patients. In both cohorts, however, a larger PNH clone was associated with classical PNH symptoms, while a smaller PNH clone was associated with marrow aplasia. Thrombosis was significantly more prevalent in white patients than Asian patients, and was associated with a significantly higher proportion of CD59-negative PMN. For individual patients, CD59-negative populations varied considerably over time, but a decreasing PNH clone portended hematopoietic failure. Survival analysis revealed a similar death rate in each group, although causes of death were different and significantly more Duke patients died from thrombosis. Japanese patients had a longer mean survival time (32.1 yr vs. 19.4 yr), although Kaplan-Meier survival curves were not significantly different. Poor survival in both groups was associated with age over 50 years, severe leukopenia/neutropenia at diagnosis, and severe infection as a complication; additionally, thrombosis at diagnosis or follow-up for Duke patients and renal failure for Japanese patients were poor prognostic factors. These data identify important differences between white and Asian patients with PNH. Identification of prognostic factors will help the design of prospective clinical trials for PNH.
Similar articles
-
Value of CD16/CD66b/CD45 in comparison to CD55/CD59/CD45 in diagnosis of paroxysmal nocturnal haemoglobinuria: An Indian experience.Indian J Med Res. 2017 Sep;146(3):362-368. doi: 10.4103/ijmr.IJMR_195_14. Indian J Med Res. 2017. PMID: 29355143 Free PMC article.
-
The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria.Blood. 1996 Jun 15;87(12):5332-40. Blood. 1996. PMID: 8652849
-
Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.Cytometry. 2000 Aug 15;42(4):234-8. doi: 10.1002/1097-0320(20000815)42:4<234::aid-cyto3>3.0.co;2-6. Cytometry. 2000. PMID: 10934342
-
Sensitive and accurate identification of PNH clones based on ICCS/ESCCA PNH Consensus Guidelines-A summary.Int J Lab Hematol. 2019 May;41 Suppl 1:73-81. doi: 10.1111/ijlh.13011. Int J Lab Hematol. 2019. PMID: 31069981 Review.
-
Paroxysmal nocturnal hemoglobinuria in children.Paediatr Drugs. 2007;9(1):11-6. doi: 10.2165/00148581-200709010-00002. Paediatr Drugs. 2007. PMID: 17291133 Review.
Cited by
-
Markers of Thrombin Generation and Inflammation in Patients with Paroxysmal Nocturnal Hemoglobinuria.Indian J Hematol Blood Transfus. 2021 Apr;37(2):204-209. doi: 10.1007/s12288-019-01239-x. Epub 2019 Nov 26. Indian J Hematol Blood Transfus. 2021. PMID: 33867725 Free PMC article.
-
Successful treatment of acute kidney injury secondary to haeme nephropathy in paroxysmal nocturnal haemoglobinuria with alkaline diuresis.EXCLI J. 2012 May 7;11:198-203. eCollection 2012. EXCLI J. 2012. PMID: 27298607 Free PMC article.
-
Presence of paroxysmal nocturnal hemoglobinuria in patients with idiopathic portal vein thrombosis: a single-center study.Turk J Med Sci. 2020 Aug 26;50(5):1344-1349. doi: 10.3906/sag-1912-204. Turk J Med Sci. 2020. PMID: 32490645 Free PMC article.
-
Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment.Int J Mol Sci. 2024 Nov 11;25(22):12104. doi: 10.3390/ijms252212104. Int J Mol Sci. 2024. PMID: 39596172 Free PMC article. Review.
-
Discovery of a second, distinct development pattern of leukemic conversion from paroxysmal nocturnal hemoglobinuria.Int J Hematol. 2025 Apr;121(4):543-546. doi: 10.1007/s12185-025-03923-3. Epub 2025 Feb 6. Int J Hematol. 2025. PMID: 39910008 Free PMC article. Review.
References
-
- Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A. 1999;96:5209-5214.
-
- Azenishi Y, Ueda E, Machii T, Nishimura J, Hirota T, Shibano M, Nakao S, Kinoshita T, Mizoguchi H, Kitani T. CD59-deficient blood cells and PIG-A gene abnormalities in Japanese patients with aplastic anaemia. Br J Haematol. 1999;104:523-529.
-
- Borowitz MJ. Flow cytometry testing in PNH. How much is enough? Cytometry. 2000;42:221-222.
-
- Brodsky RA, Mukhina GL, Nelson KL, Lawrence TS, Jones RJ, Buckley JT. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood. 1999;93:1749-1756.
-
- Brodsky RA, Mukhina GL, Li S, Nelson KL, Chiurazzi PL, Buckley JT, Borowitz MJ. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol. 2000;114:459-466.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous